Tags » GlaxoSmithKline

New GlaxoSmithKline CEO wants fewer, bigger new drug launches

GlaxoSmithKline’s (GSK.L) new chief executive aims to improve returns in drug development, and wants fewer but bigger new medicine launches.

Sourced through Scoop.it from: uk.reuters.com

Scoop.it

TechEmergence highlights how GSK used Luminoso to adjust marketing messaging

You can download the full case study here.

TechEmergence, an artificial intelligence market research firm, helps companies and institutions gain insight on the applications and implications of AI and machine learning technologies. 127 more words

Natural Language Understanding

Big Pharma conspired to destroy supply of life-saving cancer drugs by putting profit before people


Source: NaturalNews.com
Amy Goodrich
April 24, 2017

If you are familiar with the fraudulent practices of the pharmaceutical industry, then you know how much power some of these companies have. 674 more words

News

Who cares about human lives? It is profit that matters. Pharmaceutical giant plotted to drive prices of cancer drugs up to 4000%

One of the world’s leading drug companies plotted to destroy supplies of life-saving cancer medicines to drive up prices in Europe, The Times has reported. 272 more words

Aspen Pharmacare

GlaxoSmithKline Inhalers and EpiPens Recalled for Defects

ST. LOUIS (KMOX) – If someone in your family has an EpiPen or an inhaler, pay attention — both devices are being recalled because of possible defects. 200 more words

News

600,000 albuterol inhalers recalled

(CNN) — GlaxoSmithKline is recalling more than 590,000 albuterol inhalers. Three lots of Ventolin HFA 200D inhalers have been voluntarily recalled due to a potential issue with the delivery system, a spokesman for the British pharmaceutical company said. 162 more words

News

GlaxoSmithKline is voluntarily recalling nearly 600K asthma inhalers

WASHINGTON – Nearly 600,000 asthma inhalers have been recalled because of a “defective delivery system,” according to the Food and Drug Administration.

The recall affects approximately 593,000 prescription-only inhalers produced by GlaxoSmithKline, … 203 more words

News